united therapeutics glp-1 receptor agonist Top Agonists Balance Weight Loss Efficacy, Safety The Unstoppable Rise of GLP-1

GLP1R activation might reduce cardiovascular morbidity indirectly through reductions in glycaemia, blood pressure, inflammation, postprandial lipaemia and body weight

Sustained inhibition of NPY/AgRP neuronal activity by FGF1

O.OricchioF

By combining these strategies with semaglutide, you can enhance your weight loss results and achieve a healthier lifestyle

For instance, in the pivotal SURPASS-2 trial, patients receiving the highest tirzepatide dose (15 mg) achieved a mean body weight reduction of 11.2 kg, nearly twice that observed with semaglutide 1 mg (5.7 kg) (19)

Introduction: Metabolic dysfunction-associated steatotic liver disease (MASLD) affects approximately 25% of the global population [1] , and 20-30% of these cases progress to a more severe stage known as MASH [2]